
Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.

Project—which is expected to double plant’s distribution capacity—will be completed by end of Q3.

Citing FDA’s slow guidance, the American Pharmacists Association is requesting delay in November 2023 DSCSA enforcement.

A breakdown of how the industry is using these lessons to move full steam ahead.

Platform expected to allow customers to meet various logistics requirements, company says.

Reflects company’s identity and pharma supply chain impact

Cold chain company’s supply chain services experience to help facilitate therapy transport

Provider will be CDMO’s primary material supplier in the lab, clinical, and production settings

Global demand for advanced storage devices likely to fuel growth opportunities

Award given in recognition of CDMO’s commitment to promoting sustainable future

Phoenix location will be company’s first to focus on high-density microarrays for diagnostic and life science research

Action enables the company to begin offering its unit-load device for shipments

Statistics show a 13.7% decrease compared to November 2021.

Capacity is below 2021 levels

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio

Company offers less-than-24-hour delivery throughout Germany

Featuring manufacturing technology, the new facility supports medicines supply chain resilience

Will grow rental program that features environmentally friendly packaging

UAE-based carrier earns recertification based on its compliance to pharma regulations

With purchase, UPS Healthcare can grow coverage in Europe, LATAM

While this concern is causing ripples in the global supply chain, technological and regulatory advances can help address the issue

Alliance revolves around interoperability of pharma products as they move through the supply chain

Recession warnings impacting the flow of goods and services

Prescription drugs are the main drivers in this effort

Storage perk will be a mainstay at facility near Frankfurt Airport

Center, expected in 2023, will support pharma and med device sectors